A simple approach to develop a paper-based biosensor for real-time uric acid detection.

The current work reports the development of an inexpensive real-time sensing module for uric acid detection on a simple, disposable paper substrate. Detection is based on a capacitive measurement system using functional ZnO hexagonal rods on pulse-electrodeposited Cu interdigitated electrodes (IDEs) over hydrophobic A4 paper. Both the prepared hydrophobic A4 paper and ZnO hexagonal rods are well characterized using field emission scanning electron microscopy (FESEM), energy dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD), UV-visible spectrophotometry (UV-Vis), Raman spectroscopy, and contact angle measurement. Arduino IDE software is used to configure the Arduino Mega board to evaluate the change in the capacitance value and to display the corresponding uric acid concentration on a liquid crystal display (LCD) screen. The experimental result shows the linear relationship in the range of 0.1 mM-1 mM concentration of uric acid with a high sensitivity of 9.00 µF mM-1 cm-2 at 0.1 mM. The results indicate that the developed capacitance measurement unit can be employed for the early screening of uric acid in real samples for clinical applications. The reported proof-of-concept has huge potential towards the development of a disposable and inexpensive biosensor platform.

Ovarian cancer with osteoblastic bone metastasis - A rare case report.

ABSTRACT: Ovarian cancer with bone involvement occurs rarely with an incidence of 0.1-0.12%. The common sites of bone metastasis are vertebrae, pelvic bones, and the skull. Patients present with severe localized bone pain, swelling, and difficulty in walking. We report a rare case of a 53-year-old female with metastatic epithelial serous adenocarcinoma of the ovary presented with multiple bony lesions in pelvic bones involving the sacrum, bilateral ilium, ischium and pubic bones and the right femur in the region of greater trochanter, smaller lesions in the left femur, and dorso lumbar vertebral metastasis while undergoing treatment as a part of distant spread. Radiologically, the osteolytic lesions are the most common, but in our case, the lesions are osteoblastic, which is rare.

Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.

ABSTRACT
Large Tumor Suppressor (LATS2) gene are Tumor Suppressor gene, linked with epigenetic modifications. LATS2 promoter hypermethylation is an important epigenetic silencing mechanism leading to cancer. Cancer is the most common, vicious and dangerously increasing diseases of the world today, associated with high morbidity and mortality. Oral cancers (OC) are the blazing universal dilemma and is the sixth most frequent cancer observed in Indian population. Tobacco consumption is the main cause of the increase in OSCC. The association between LATS2 in the pathogenesis of cancers propose that their combination might be studied as a possible molecular marker for particular subgroups of patients. Therefore, the present study tried to investigate whether LATS2 promoter methylation was associated with oral squamous cell carcinoma (OSCC) in North Indian subjects. DNA methylation quantitative studies of LATS2 Tumor Suppressor genes were performed by methylation-specific polymerase chain reaction (MSP). 38 out of 70 patients (55 %) were found to be methylated for LATS2 gene, a statistically significant result was obtained (p-value < 0.005) for LATS2 genes. The results suggest that epigenetic changes may be related to the down-regulation of LATS2 expression. It can be concluded that LATS2 gene plays a significant role in the diagnosis of cancer and provide a better alternative as a diagnostic biomarker. Our data infer that a low LATS2 expression due to methylation may contribute to the cancer progression and could be useful for the diagnosis of OSCC. Therefore, investigation of promoter methylation in such genes may provide a biomarker which may prove to be useful in early detection of Oral Cancer.
Keywords: Oral squamous cell carcinoma (OSCC), Epigenetic changes, LATS2 gene, Promoter Hypermethylation, Methylation-Specific PCR (MSP), Biomarkers
Abbreviations: OSCC- Oral Squamous Cell Carcinoma; DNA- Deoxyribonucleic acid; LATS-Large Tumor Suppressor (gene); MSP-Methylation-Specific Polymerase Chain Reaction.